Zenith Flex G48422Recalls & reported problems
Cook Incorporated · Zenith Flex, AAA Endovascular Graft Main Body · Class 3 · Implant
All models of Zenith Flex (54)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 9
- Deaths reported
- 1
- Injuries reported
- 6
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 9 adverse event reports that list this exact device (DI 10827002484228), received between Apr 18, 2016 and Oct 11, 2022 — classified as 1 death, 6 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Fluid/Blood Leak” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Fluid/Blood Leak3
- Adverse Event Without Identified Device or Use Problem1
- Bent1
- Complete Blockage1
- Device Expiration Issue1
- Difficult or Delayed Activation1
- Difficult or Delayed Positioning1
Patient problems
- No Code Available4
- No Known Impact Or Consequence To Patient2
- Death1
- Failure of Implant1
- Insufficient Information1
- Thrombosis/Thrombus1
- Thrombus1
Recent adverse event reports
The 9 most recent of 9 reports, in the reporter's own words as published by the FDA.
InjuryOct 11, 2022Fluid/Blood Leak; Fluid/Blood Leak
IT WAS REPORTED THE PATIENT NEEDED AN ADDITIONAL GRAFT AFTER THE PLACEMENT OF A ZENITH FLEX AAA ENDOVASCULAR GRAFT BIFURCATED MAIN BODY. THE PHYSICIAN DISCOVERED A TYPE 3 ENDOLEAK ONE MONTH POST OPERATION DURING A FOLLOW-UP COMPUTED TOMOGRAPHY (CT) SCAN AND ULTRASOUND. THE ENDOLEAK WAS FOUND IN THE "CRUTCH OF THE MAIN BODY." THE ANEURYSM SAC APPEARED TO BE STABLE AND HAD NO INCREASE IN SIZE. THE GRAFTS REMAINED IN SITU AND NO UNINTENDED PART OF THE DEVICE REMAINED INSIDE THE BODY OF THE PATIENT. THE PHYSICIAN HAS ASKED COOK PLANNING SERVICE TO PLAN AN ADDITIONAL GRAFT FOR RELINING. THE PATIENT WAS REPORTED TO BE STABLE. NO OTHER ADVERSE EFFECTS WERE REPORTED FOR THIS INCIDENT.
Patient problems: Failure of Implant
MAUDE report 15578876 ↗InjuryJun 25, 2021Complete Blockage; Complete Blockage
NO ADDITIONAL INFORMATION REGARDING THE PATIENT AND/OR EVENT HAS BEEN RECEIVED SINCE THE PREVIOUS MEDWATCH REPORT WAS SENT.
Patient problems: Insufficient Information; Thrombosis/Thrombus
MAUDE report 12069143 ↗InjuryJun 23, 2020Difficult or Delayed Activation; Difficult or Delayed Activation
IT WAS REPORTED THAT THE TOP CAP OF A ZENITH FLEX AAA ENDOVASCULAR GRAFT BIFURCATED MAIN BODY WAS UNABLE TO BE RELEASED DURING AN AAA PROCEDURE. THE DEVICE WAS INITIALLY PLACED WITH NO ISSUES. THE GRAFT WAS DEPLOYED WITHOUT PROBLEMS, HOWEVER IT WAS REPORTED THAT THE TOP CAP WAS UNABLE TO BE RELEASED. THE USER ATTEMPTED TROUBLESHOOTING TECHNIQUES WITHOUT SUCCESS. THE PHYSICIAN CONVERTED TO AN OPEN REPAIR TO REMOVE THE DEPLOYED TFFB DEVICE. IT WAS LATER REPORTED THAT THE DISTAL TRIGGER WIRE WAS RELEASED WITHOUT PROBLEMS PRIOR TO ADVANCING THE TOP CAP, AND THERE WAS NO PROBLEM REMOVING THE PROXIMAL TRIGGER WIRE. DURING TROUBLESHOOTING, THE PHYSICIAN WAS ABLE TO REMOVE ALL TRIGGER WIRES WITHOUT PROBLEMS AND THE FIRST CENTIMETER OF TOP CAP ADVANCEMENT WAS SUCCESSFUL, UNTIL IT COULD NOT BE ADVANCED FURTHER. THE PHYSICIAN ATTEMPTED TO ADVANCE WITH MILD FORCE BUT WAS UNABLE, AS MORE FORCE WOULD HAVE CAUSED THE INNER CANNULA TO KINK. AFTER OPENING THE PATIENT, THE PARTIALLY DEPLOYED GRAFT WAS EXPLANTED BY CUTTING THE INNER CANNULA. AN ATTEMPT TO REMOVE THE TOP CAP OUTSIDE OF THE BODY WAS COMPLETED WITH "EXTREME FORCE". THE PHYSICIAN THEN STOPPED TO ENABLE AN INVESTIGATION. THE POSITION OF T
Patient problems: No Code Available
MAUDE report 10186226 ↗InjuryMay 9, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
NO ADDITIONAL INFORMATION REGARDING THE PATIENT AND/OR EVENT HAS BEEN RECEIVED SINCE THE PREVIOUS MEDWATCH REPORT WAS SENT.
Patient problems: No Code Available; Thrombus
MAUDE report 8596492 ↗MalfunctionJan 31, 2019Fluid/Blood Leak; Fluid/Blood Leak
NO NEW EVENT DESCRIPTION INFORMATION TO REPORT AT THIS TIME.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8294798 ↗InjuryOct 30, 2018Fluid/Blood Leak; Fluid/Blood Leak
IT WAS REPORTED THE FOLLOWING DEVICES WERE IMPLANTED ON (B)(6) 2014, WITH CONTINUING ANEURYSM GROWTH. G48422-TFFB-30-82-ZT, LOT 447811 G55239-ZSLE-16-90-ZT, LOT 4247510 G55239-ZSLE-16-90-ZT, LOT 4537245 G32184-ESBE-32-39, LOT 3438589 IN 2017, THEY COILED THE PATIENT'S INFERIOR MESENTERIC ARTERY (IMA) BECAUSE THEY THOUGHT THERE WAS A LEAK. DUE TO PERSISTENT ENDOLEAK, AN OPEN ABDOMINAL AORTIC ANEURYSM REPAIR WAS PERFORMED ON (B)(6) 2018. WHEN THEY OPENED THE ANEURYSM TO EXAMINE THE DEVICE, BLOOD WAS SQUIRTING THROUGH THE SUTURE HOLES OF THE DEVICE. THEY EXPLANTED THE DEVICE. THE COMPLAINT DEVICES WERE DISPOSED OF BY THE CUSTOMER. ADDITIONAL PATIENT, DEVICE AND EVENT DETAILS HAVE BEEN REQUESTED BUT HAVE NOT YET BEEN FORTHCOMING AT THE TIME OF THIS REPORT.
Patient problems: No Code Available
MAUDE report 8021511 ↗InjuryNov 28, 2016Bent; Bent
AN EVAR PROCEDURE WAS BEING PERFORMED ON THE (B)(6) YEAR OLD MALE PATIENT. WHEN RETRIEVING THE TOP CAP, THE SUPRARENAL STENT GOT CAUGHT AND BENT. THE USER HAD TO CONVERT TO AN AUI AND USED 2 ADDITIONAL DEVICES TO COMPLETE THE PROCEDURE. NO ADVERSE CONSEQUENCE TO THE PATIENT.
Patient problems: No Code Available
MAUDE report 6128995 ↗MalfunctionOct 12, 2016Difficult or Delayed Positioning; Difficult or Delayed Positioning
NO ADDITIONAL INFORMATION WAS RECEIVED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 6020022 ↗DeathApr 18, 2016Device Expiration Issue; Device Expiration Issue
THE PATIENT ARRIVED TO THE EMERGENCY ROOM WITH A RUPTURED ABDOMINAL AORTA. IT WAS DECIDED THAT THEY WERE GOING TO TRY AND PERFORM AN ENDOVASCULAR PROCEDURE IN ORDER TO SAVE THE PATIENT¿S LIFE. THE PATIENT CODED WHILE IN THE ER AND WAS IMMEDIATELY TRANSPORTED TO THE OR. IN THE OR IT WAS DETERMINED THAT THE GRAFT NEEDED FOR THE REPAIR HAD AN EXPIRED DATE, BUT THEY FELT IT WAS STILL THE PATIENTS ONLY OPTION AT THE TIME SO IT WAS IMPLANTED. ACCORDING TO THE INITIAL REPORTER, THE PATIENT DID NOT SURVIVE THE PROCEDURE DUE TO THE MASSIVE AMOUNT OF INTERNAL BLEEDING FROM THE RUPTURED AORTA.
Patient problems: Death
MAUDE report 5584649 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page